• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

直观分期与 King 的临床分期相关。

Intuitive Staging Correlates With King's Clinical Stage.

机构信息

Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, King's College London, London, UK.

Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK.

出版信息

Amyotroph Lateral Scler Frontotemporal Degener. 2021 Aug;22(5-6):336-340. doi: 10.1080/21678421.2020.1867181. Epub 2021 Apr 6.

DOI:10.1080/21678421.2020.1867181
PMID:33821690
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7611335/
Abstract

Clinical stage in amyotrophic lateral sclerosis (ALS) can be assigned using King's staging with a simple protocol based on the number of CNS regions involved and the presence of significant nutritional or respiratory failure. It is important that the assigned clinical stage matches expectations, and generally corresponds with how a health care professional would intuitively stage the patient. We therefore investigated the relationship between King's clinical ALS stage and ALS stage as intuitively assigned by health care professionals. We wrote 17 case vignettes describing people with ALS at different disease stages from very early limited disease involvement through to severe, multi-domain disease. During two workshops, we asked health care professionals to intuitively stage the vignettes and compared the answers with the actual King's clinical ALS stage. There was a good correlation between King's clinical ALS stage and intuitively assigned stage, with a Spearman's Rank correlation coefficient of 0.64 ( < 0.001). There was no difference in the intuitive stages assigned by practitioners of different types or at different levels of experience. Across a spectrum of ALS scenarios, King's clinical ALS stage corresponds to intuitive ALS stage as assigned by a range of health care professionals.

摘要

肌萎缩侧索硬化症(ALS)的临床分期可采用基于 King 分期的简单方案进行,该方案基于受累中枢神经系统区域的数量和是否存在明显的营养或呼吸衰竭。重要的是,所分配的临床分期与预期相符,并且通常与医疗保健专业人员直观地对患者进行分期的方式相对应。因此,我们研究了 King 临床 ALS 分期与医疗保健专业人员直观分配的 ALS 分期之间的关系。我们编写了 17 个病例描述,描述了不同疾病阶段的 ALS 患者,从早期局限性疾病到严重的多领域疾病。在两次研讨会上,我们要求医疗保健专业人员直观地对病例进行分期,并将答案与实际的 King 临床 ALS 分期进行比较。King 临床 ALS 分期与直观分配的分期之间存在良好的相关性,Spearman 秩相关系数为 0.64(<0.001)。不同类型或经验水平的从业者分配的直观分期没有差异。在 ALS 各种情况下,King 临床 ALS 分期与一系列医疗保健专业人员直观分配的 ALS 分期相对应。

相似文献

1
Intuitive Staging Correlates With King's Clinical Stage.直观分期与 King 的临床分期相关。
Amyotroph Lateral Scler Frontotemporal Degener. 2021 Aug;22(5-6):336-340. doi: 10.1080/21678421.2020.1867181. Epub 2021 Apr 6.
2
A standard operating procedure for King's ALS clinical staging.金氏 ALS 临床分期的标准操作流程。
Amyotroph Lateral Scler Frontotemporal Degener. 2019 May;20(3-4):159-164. doi: 10.1080/21678421.2018.1556696. Epub 2019 Feb 18.
3
Comparison of the King's and MiToS staging systems for ALS.肌萎缩侧索硬化症(ALS)的金氏分期系统与米托斯分期系统的比较。
Amyotroph Lateral Scler Frontotemporal Degener. 2017 May;18(3-4):227-232. doi: 10.1080/21678421.2016.1265565. Epub 2017 Jan 5.
4
MiToS and King's staging as clinical outcome measures in ALS: a retrospective analysis of the FORTITUDE-ALS trial.将肌萎缩侧索硬化症(ALS)的MiToS和金氏分期作为临床结局指标:FORTITUDE-ALS试验的回顾性分析
Amyotroph Lateral Scler Frontotemporal Degener. 2023 May;24(3-4):304-310. doi: 10.1080/21678421.2022.2154678. Epub 2022 Dec 12.
5
Staging model for amyotrophic lateral sclerosis in Singapore.新加坡肌萎缩侧索硬化分期模型。
Singapore Med J. 2022 Jul;63(7):371-375. doi: 10.11622/smedj.2021001. Epub 2021 Jan 21.
6
Comparison of the ability of the King's and MiToS staging systems to predict disease progression and survival in amyotrophic lateral sclerosis.比较 King 分期系统和 MiToS 分期系统预测肌萎缩侧索硬化疾病进展和生存的能力。
Amyotroph Lateral Scler Frontotemporal Degener. 2021 Nov;22(7-8):478-485. doi: 10.1080/21678421.2021.1903506. Epub 2021 Apr 8.
7
The utility of ALS staging systems in a multi-ethnic patient cohort.多民族患者队列中 ALS 分期系统的效用。
Amyotroph Lateral Scler Frontotemporal Degener. 2021 Aug;22(5-6):341-349. doi: 10.1080/21678421.2021.1893336. Epub 2021 Mar 16.
8
Disease survival and progression in TARDBP ALS patients from Sardinia, Italy.意大利撒丁岛 TARDBP ALS 患者的疾病生存和进展。
J Neurol. 2024 Feb;271(2):929-934. doi: 10.1007/s00415-023-12037-x. Epub 2023 Oct 19.
9
Deconstructing progression of amyotrophic lateral sclerosis in stages: a Markov modeling approach.分期解析肌萎缩侧索硬化症的进展:一种马尔可夫建模方法。
Amyotroph Lateral Scler Frontotemporal Degener. 2018 Nov;19(7-8):483-494. doi: 10.1080/21678421.2018.1484925. Epub 2018 Jul 12.
10
Hippocampal subfield and anterior-posterior segment volumes in patients with sporadic amyotrophic lateral sclerosis.散发性肌萎缩侧索硬化症患者的海马亚区和前后节段体积。
Neuroimage Clin. 2021;32:102816. doi: 10.1016/j.nicl.2021.102816. Epub 2021 Sep 15.

引用本文的文献

1
Assessment of the Clinical and Functional Health Status of Patients with Amyotrophic Lateral Sclerosis during the COVID-19 Pandemic in Brazil Using Telemedicine.在巴西新冠疫情期间使用远程医疗评估肌萎缩侧索硬化症患者的临床和功能健康状况
Healthcare (Basel). 2024 Mar 11;12(6):627. doi: 10.3390/healthcare12060627.

本文引用的文献

1
Brain metabolic changes across King's stages in amyotrophic lateral sclerosis: a F-2-fluoro-2-deoxy-D-glucose-positron emission tomography study.肌萎缩侧索硬化症 King 分期的脑代谢变化: F-2-氟-2-脱氧-D-葡萄糖正电子发射断层扫描研究。
Eur J Nucl Med Mol Imaging. 2021 Apr;48(4):1124-1133. doi: 10.1007/s00259-020-05053-w. Epub 2020 Oct 7.
2
Cortical thinning trajectories across disease stages and cognitive impairment in amyotrophic lateral sclerosis.肌萎缩侧索硬化症不同疾病阶段和认知障碍中的皮质变薄轨迹
Cortex. 2020 Oct;131:284-294. doi: 10.1016/j.cortex.2020.07.007. Epub 2020 Jul 29.
3
Costs of illness in amyotrophic lateral sclerosis (ALS): a cross-sectional survey in Germany.
肌萎缩侧索硬化症(ALS)的疾病经济负担:德国的一项横断面调查。
Orphanet J Rare Dis. 2020 Jun 12;15(1):149. doi: 10.1186/s13023-020-01413-9.
4
Cortical hyperexcitability evolves with disease progression in ALS.肌萎缩侧索硬化症(ALS)中皮质兴奋性随着疾病进展而演变。
Ann Clin Transl Neurol. 2020 May;7(5):733-741. doi: 10.1002/acn3.51039. Epub 2020 Apr 18.
5
Health Utilities and Costs for Motor Neurone Disease.运动神经元病的健康效用和成本。
Value Health. 2019 Nov;22(11):1257-1265. doi: 10.1016/j.jval.2019.05.011. Epub 2019 Aug 1.
6
Clinical disease stage related changes of serological factors in amyotrophic lateral sclerosis.肌萎缩侧索硬化症患者血清学因素与临床疾病分期的相关性变化。
Amyotroph Lateral Scler Frontotemporal Degener. 2019 Feb;20(1-2):53-60. doi: 10.1080/21678421.2018.1550516. Epub 2019 Feb 20.
7
ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS.肌萎缩侧索硬化症(ALS)特异性认知和行为变化与疾病进展阶段相关。
Neurology. 2018 Oct 9;91(15):e1370-e1380. doi: 10.1212/WNL.0000000000006317. Epub 2018 Sep 12.
8
The life expectancy of Stephen Hawking, according to the ENCALS model.根据欧洲慢性透析和移植注册(ENCALS)模型得出的斯蒂芬·霍金的预期寿命。
Lancet Neurol. 2018 Aug;17(8):662-663. doi: 10.1016/S1474-4422(18)30241-2. Epub 2018 Jul 17.
9
Progress and new frontiers in biomarkers for amyotrophic lateral sclerosis.肌萎缩侧索硬化症生物标志物的进展与新前沿
Biomark Med. 2018 Jul;12(7):693-696. doi: 10.2217/bmm-2018-0149. Epub 2018 Jun 1.
10
Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model.肌萎缩侧索硬化症患者的预后:个体化预测模型的建立和验证。
Lancet Neurol. 2018 May;17(5):423-433. doi: 10.1016/S1474-4422(18)30089-9. Epub 2018 Mar 26.